|Articles|March 1, 2004
- Pharmaceutical Executive-03-01-2004
Table of Contents
Table of Contents
Advertisement
Articles in this issue
over 22 years ago
DTC: European Styleover 22 years ago
The Ins and Outs of EAPsover 22 years ago
Is Everyone a Target?over 22 years ago
The Push for Modern ManufacturingAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Trump Administration Preparing New Round of Medicaid Drug-Pricing Deals: Report
2
M&A Roundup: DualityBio & Genentech Enter Partnership to Develop Next Generation ADC’s, Teva Bids to Acquire Igalmi from BioXcel
3
Study Shows Link Between Zepbound and Lower Healthcare Costs in Adults Aged 55 and Up with Obesity: Report
4
Pharmaceutical Executive Daily: DualityBio and Teva Strike Major Biopharma Deals
5